Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease

Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease

IntroductionBlepharospasm is uncommon in Parkinson's disease, especially in the peak-dose dyskinesia period.Case presentationWe herein present the case of a patient with PD who developed blepharospasm in the peak-dose dyskinesia period. The symptom was improved by taking amantadine.ConclusionTh...

Full description

Bibliographic Details
Main Authors: Qian-Ya Fan, Xiao-Dong Zhang, Ze-Di Hu, Shi-Shi Huang, Shi-Guo Zhu, Cai-Ping Chen, Xiong Zhang, Jian-Yong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Neurology
Subjects:
blepharospasm
Parkinson's disease
peak-dose dyskinesia
amantadine
dyskinesia
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.961758/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.961758/full

Similar Items